Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
6.54
+0.06 (0.93%)
At close: Feb 27, 2026
Market Cap3.30B +0.5%
Revenue (ttm)1.88B -14.1%
Net Income62.34M +23.7%
EPS0.11 +12.1%
Shares Out534.07M
PE Ratio58.59
Forward PEn/a
Dividend0.15 (2.31%)
Ex-Dividend DateJun 5, 2025
Volume5,407,081
Average Volume7,867,055
Open6.51
Previous Close6.48
Day's Range6.44 - 6.54
52-Week Range5.22 - 7.53
Beta0.63
RSI56.88
Earnings DateApr 30, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Sector Healthcare
Founded 1990
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2024, SHA:600613's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.

Financial Statements